Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
about
I-domain-antigen conjugate (IDAC) for delivering antigenic peptides to APC: synthesis, characterization, and in vivo EAE suppressionVaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APCCirculating adhesion molecules in obstructive sleep apnea and cardiovascular disease.Polymeric materials for theranostic applications.Decreased expression of the β2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice.
P2860
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
@ast
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
@en
type
label
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
@ast
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
@en
prefLabel
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
@ast
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes.
@en
P2093
P2860
P356
P1433
P1476
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes
@en
P2093
Bimo A Tejo
David S Moore
Heather Shinogle
Prakash Manikwar
Tahl Zimmerman
Teruna J Siahaan
P2860
P304
P356
10.7150/THNO/V01P0277
P577
2011-05-10T00:00:00Z